Rosenberg Matthew Hamilton boosted its position in The Cigna Group (NYSE:CI – Free Report) by 29.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 687 shares of the health services provider’s stock after acquiring an additional 155 shares during the quarter. Rosenberg Matthew Hamilton’s holdings in The Cigna Group were worth $190,000 at the end of the most recent reporting period.
Several other institutional investors have also added to or reduced their stakes in CI. Greenfield Savings Bank boosted its stake in shares of The Cigna Group by 28.2% in the 4th quarter. Greenfield Savings Bank now owns 2,578 shares of the health services provider’s stock valued at $712,000 after purchasing an additional 567 shares in the last quarter. Miracle Mile Advisors LLC boosted its holdings in shares of The Cigna Group by 0.6% during the 4th quarter. Miracle Mile Advisors LLC now owns 16,681 shares of the health services provider’s stock valued at $4,606,000 after acquiring an additional 105 shares in the last quarter. Wedmont Private Capital grew its position in The Cigna Group by 8.7% during the 4th quarter. Wedmont Private Capital now owns 4,664 shares of the health services provider’s stock worth $1,301,000 after acquiring an additional 373 shares during the last quarter. Trust Co. of Toledo NA OH increased its holdings in The Cigna Group by 6.2% in the 4th quarter. Trust Co. of Toledo NA OH now owns 1,032 shares of the health services provider’s stock worth $285,000 after purchasing an additional 60 shares in the last quarter. Finally, Fiduciary Alliance LLC acquired a new stake in shares of The Cigna Group during the fourth quarter valued at about $252,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
CI has been the topic of a number of research reports. Deutsche Bank Aktiengesellschaft reduced their target price on shares of The Cigna Group from $398.00 to $394.00 and set a “buy” rating on the stock in a report on Monday, November 4th. Jefferies Financial Group lifted their price objective on shares of The Cigna Group from $402.00 to $422.00 and gave the company a “buy” rating in a research note on Tuesday, September 17th. Barclays increased their target price on shares of The Cigna Group from $405.00 to $420.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 5th. Royal Bank of Canada dropped their price objective on shares of The Cigna Group from $384.00 to $377.00 and set an “outperform” rating on the stock in a report on Friday, November 1st. Finally, Piper Sandler restated an “overweight” rating and issued a $394.00 target price (up from $392.00) on shares of The Cigna Group in a research note on Tuesday, November 5th. One investment analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and an average price target of $395.93.
The Cigna Group Trading Up 0.9 %
NYSE:CI opened at $281.54 on Tuesday. The company has a market cap of $78.31 billion, a P/E ratio of 26.56, a P/E/G ratio of 0.88 and a beta of 0.54. The Cigna Group has a 1 year low of $262.03 and a 1 year high of $370.83. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.72 and a quick ratio of 0.72. The stock’s fifty day moving average price is $304.16 and its two-hundred day moving average price is $328.02.
The Cigna Group (NYSE:CI – Get Free Report) last announced its quarterly earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.22 by $0.29. The firm had revenue of $63.70 billion for the quarter, compared to the consensus estimate of $59.58 billion. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The company’s revenue for the quarter was up 29.8% on a year-over-year basis. During the same period in the prior year, the firm posted $6.77 earnings per share. As a group, analysts expect that The Cigna Group will post 28.5 EPS for the current year.
The Cigna Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, December 19th. Investors of record on Wednesday, December 4th were given a $1.40 dividend. The ex-dividend date was Wednesday, December 4th. This represents a $5.60 dividend on an annualized basis and a dividend yield of 1.99%. The Cigna Group’s dividend payout ratio (DPR) is presently 52.83%.
About The Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Read More
- Five stocks we like better than The Cigna Group
- Using the MarketBeat Dividend Yield Calculator
- Cintas: Trade Uncertainty Creates a Buy-the-Dip Opportunity
- 3 Healthcare Dividend Stocks to Buy
- 3 Stocks to Benefit From China’s Rare Earth Export Ban on U.S.
- Why Are Stock Sectors Important to Successful Investing?
- Why Goldman Sachs Just Upgraded These 3 Stocks and What It Means
Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.